A detailed history of Groupama Asset Managment transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Groupama Asset Managment holds 1,337 shares of CRL stock, worth $248,374. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,337
Previous 1,313 1.83%
Holding current value
$248,374
Previous $271 Million 22.05%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$187.96 - $245.29 $4,511 - $5,886
24 Added 1.83%
1,337 $211 Million
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $114,133 - $148,607
553 Added 72.76%
1,313 $271 Million
Q1 2024

May 14, 2024

SELL
$203.52 - $273.43 $236,490 - $317,725
-1,162 Reduced 60.46%
760 $396 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $316,207 - $459,050
1,922 New
1,922 $455 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.